elevated ALT (CAH 5). In the HCV− subgroup, none of the seven HGV+ viraemic patients had elevated Introduction. The newly discovered (1995) hepatitis G ALT and liver biopsy was not performed. virus (HGV ) is an RNA virus from the Flaviviridae Conclusion. HGV infection prevalence is high (44%) family with 85% genomic homology to GB virus C in RTR, but clearly independent of HCV status and/or (GBV-C ). We studied the prevalence of HGV infection the geographical origin of the recipients. This data among a cohort of 398 renal transplant recipients indicates a different epidemiology as compared to our (RTR), all of whom had previously received blood HCVs previous experience. transfusions, been grafted between August 1984 and December 1991, and been treated by cyclosporin A Key words: epidemiology; geographical location; hepat-(CsA) as the main immunosuppressant.
Introduction

M vs 44 F; 29 French vs 77 non-French) and an HCV −ve subgroup (264 RTR; 181 M vs 83 F, 196
Renal transplant recipients (RTR) are at increased French vs 68 non-French). We randomly selected 27 risk of infection from transmitted viral agents. Non A, RTR in the HCV+/HBV− subgroup (14 M vs 13 F, non B Hepatitis has been recognized as a relevant 10 French vs 17 Italians) and 27 RTR in the problem for more than 10 years.
HCV−/HBV− subgroup (19 M vs 8 F, 18 French vs
In recent years we have seen the identification of 9 Italians) for HGV screening.
hepatitis C virus (HCV ) [1] and the introduction of The detection of HGV RNA sequences in serum assays for the detection of antibodies against HCV [2] . (viraemia) was done by double nested RT-PCR using Recently two isolates of a new virus designated specific primers chosen in the 5∞ non-coding genomic hepatitis GB virus C (GBV-C ) and hepatitis G virus region. The serum detection of specific antibodies (anti (HGV ) were identified from patients with viral hepat-E2) was done by ELISA test. All sera (at time of liver itis [3] . They should be considered identical as the biopsy or at last follow-up) were tested in duplicate.
amino-acid sequences of the two isolates share 95% Results. The prevalence of HGV viraemia was 26%
homology. The genomic organization of this HGV (14/54) in the whole group and in both HCV +ve and places it in the family of Flaviviridae, which includes −ve subgroups (7/27). The prevalence of HGV infec-HCV [4] . tion (viraemia+ and/or anti E2 antibodies+) was 44%
The aim of this work was to establish the prevalence (24/54) in the whole group and in both HCV +ve and of HGV infection in random samples of a large cohort −ve subgroups (12/27). In addition, the prevalence of RTR [5] , according to mainly the HCV status of was similar in males vs females and in French vs the recipients, but also to their respective origin foreigners recipients (mostly Italians). In the HCV ( French residents vs non-residents, i.e. foreigners). +ve subgroup, the seven HGV viraemia-positive patients who previously had liver biopsies disclosed as of December 1996 was 84 months with a range from 60 Choice of primers to 160 months. From the start, all the patients received a triple therapy of CsA+prednisolone+azathioprine. All The primers for the nested PCR were chosen in the 5∞ nonrecipients were transfused prior to transplantation either coding highly conserved genomic region of virus isolates because of severe anaemia or most often as part of a specific designated PNF 2161, R 10291, and GBV-C [4] . 15 pmol of sense primer, 12 pmol of antisense outer respectively. The mean duration of chronic haemodialysis primer, and 1.25 U of Taq polymerase (50 ml final was respectively 48 months (SD=39, 11-156 with only one volume). After an initial melting time of 94°C, 3 min, pre-emptive renal transplantation) in the HCV+ sample vs the thermocycling conditions for this PCR used 40 cycles 18 months (SD=23, 1-102 with four pre-emptive transof denaturation (94°C 20 s), annealing (55°C, 30 s), plantations). This difference was already significant in the extension (72°C, 1 min), followed by a 2-min extension original groups [6, 7] .
Subjects and methods
at 72°C. The mean follow-up time from the onset of transplantation These conditions were adapted to a Hybaid thermal to last visit (or graft failure) was 97 months (SD=24, Reactor HBTR 1 L. 54-135) in the HCV+ sample vs 66 months (SD=39, $ Second round of PCR: it was performed on 3 ml of the 0.5-115) in the HCV− sample (P=NS).
first PCR products if no amplification was obtained. Therefore the study was a cross-sectional survey done on
The PCR mixture was as described above, but 20 pmol serum samples aliquoted in 350 ml and stored at −70°C for of each of the inner primers were added. Only 30 cycles months or years. The samples selected were either at time of of thermocycling as described above were performed. liver biopsy or at last follow-up. All sera were tested in $ Detection of amplification products: The amplification duplicate.
products were analysed by agarose gel electrophoresis (30 min, 150 V ) and were visualized under UV illumination after staining with ethidium bromide. Positive and negative samples were tested.
Methods
For the first PCR products, the size of the visualized band was 443 bp.
For the second PCR products, the band size was
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363 bp.
$
Controlled hybridization: After electrophoresis, the agarose gel containing the PCR products were transfered
RNA extraction
to Hybond N Nylon membrane and submitted to a hybridization under low stringency to a radiolabelled Total RNA was extracted from sera according to the probe consisting of an oligonucleotide fragment Chomczynski technique [8] . Briefly, 350 ml of serum was from the 5∞ non-coding region: positions 161-179: incubated with guanidinium isothiocyanate plus Na acetate.
5∞GGTAGCCACTATAGGTGGG3∞ [11] . Chloroform/isoamyl alcohol (2451) was then added, vortexed, and centrifuged. The aqueous supernatant phase was This fragment was labelled with *P32 using a kit 'Oligonucleotide 5∞ End Labelling system' (NEP 101; NEN ). mixed with 500 ml of isopropanol for RNA precipitation (−20°C, 2 h). The pellet of RNA was washed with 70% In brief, the 5∞ end of the DNA fragments were labelled using the ATP* (g32P) and polynucleotide kinase by direct alcohol. phosphorylation of the 5' hydroxy groups (exchange were HGV-RNA positive: three females and four reaction). males, six French and one Italian. The same prevalence After extensive washing with low-stringency solution, the of HGV infection was observed: 26% (7/27). membrane was exposed for 30 min to X-ray-sensitive films (Biomax MR, Kodak). The samples were considered HGV positive if hybridizable products were detected on the film.
Serum anti-HGV antibodies (Table 2)
Now, for greater convenience, we are including in each Overall we have found 13 positive recipients out of 54 assay a negative and two known positive (weak and strong) samples as controls and we are visualizing the bands under (24%) with eight in the HCV+ subgroup (8/27, 30%) UV. and five in the HCV− subgroup (5/27, 19%).
Detection in serum of specific antibodies against HGV Prevalence of HGV infection (Table 2) (anti-E2)
The combination of HGV viraemia and anti-E2 antiIn addition, we tested the presence of anti-envelope (E2) bodies detection indicated an overall HGV infection antibodies against HGV in the same serum samples. The prevalence of 44% (24/54) split into active infection technique used is an ELISA test detecting IgG antibodies (positive viraemia) in 26% and past infection (anti-E2 directed against the E2 structural antigen, which indicates a antibodies alone) in 18%. Note that three patients were past HGV infection and is usually considered as a marker at the same time viraemic and antibody positive. The for recovery (Boehringer Mannheim; Micro Plate Anti-HG HGV infection prevalence was identical in both HCV+ env; Meylan, France).
and HGV− subgroups (12/27, 44%). difference was not significant.
Statistical analyses Correlation with gender
Results
Correlation with origin of the recipients
The random selection The HGV positivity was 43% in French residents (12 of 28) as compared to 12 of 26 (46%) in non-residents The results of the random selection of patients to be (P=NS). tested in the HCV+/HBV− and HCV−/HBV− subgroups are shown in Table 1 .
Liver consequences HGV viraemia prevalence (Table 2)
In the HCV+ sample group, the seven co-infected patients (HCV+ and HGV viraemia+) had previously Fourteen of the 54 patients tested were HGV-RNA positive, which gave an overall prevalence of 26% for had liver biopsies which disclosed normal livers in three and chronic active hepatitis in four ( Knodell HGV infection in RTR.
In the HCV+ subgroup, seven patients were also scores at 4, 5, 6 and 8). Only one patient had elevated ALT (>×1.5 normal value) at time of biopsy (CAH= HGV-RNA positive: five females and two males, six Italians and one French. The prevalence of HGV 5). In the HCV− sample, all HGV infected patients had normal ALT and therefore none underwent liver infection in the HCV+ subgroup was therefore seven of 27 (26%). In the HCV− subgroup, seven patients biopsy. 
P=NS. *Exclusion of 28 patients co-infected or infected by hepatitis B virus (HBsAg+). 
Prevalence of HGV infection on haemodialysis
Discussion
In an extensive Japanese study [12] , the prevalence of Validity of the random selection of patients (Table 1) HGV infection (based on positive viraemia) among haemodialysed patients was estimated to be 3% We had previously studied the epidemiology of (16/519) as compared to 0.9% in local blood donors HCV infection in this RTR cohort [6, 7] . In the (4/448). Contrasted with a Spanish study [13] , which HCV+/HBV− subgroup (106 patients), the proporfound a prevalence of 26% (25/96) among haemodiation of men was 58% (62/106) vs 52% (14/27) in the lysed patients, as compared to 3% in blood donors random sample. The proportion of French was 27% (6/200), and two further Italian studies [14, 15] , which (29/106) as compared to 37% (10/27) in the random disclosed a prevalence of 19% (19/100) and of 6% sample. There was no statistical difference between the (11/172) respectively. subgroups.
In the HCV−/HBV− subgroup (264 patients) the proportion of men and French were respectively 69%
Prevalence of HGV infection in transplantation (181/264) and 74% (196/264) as compared to 70% (19/27) and 67% (18/27) in the random sample. There In a very limited Italian study [15] , the prevalence of was no statistical difference. This allowed us to use the HGV infection (also based on positive viraemia) in results obtained as representative of the whole cohort. renal transplantation was estimated to be 36% (4/11). The reasons were mainly to save time, money, and An American study [16 ] This is in contrast to a limited paediatric study [19] Overall the respective prevalences of HCV and HGV where the prevalence was much higher at 55% (6/11). were 29% (116/398 and 106/370) and 44% (24/54) Prevalence of HGV infection in liver transplantation in the same population. In previous studies [6, 7] was estimated to be 20% (17/86) before transplantation we showed that the prevalence of HCV infection and 50% after liver transplantation (43/86) in an was significantly lower (P=0.0001) in French (13%, Italian study [20] . Similar results were found in 29/225) as compared to foreigners (53%, 77/145) with an American study [21] with a post-liver-trans-51% in Italians (69/135). For HGV, the prevalence is plantation prevalence of 64% (28/44) as compared to similar in the French (43%, 12/28) and in the Italians 14% (13/91) in liver diseased patients (without trans-(46%, 12/26). plantation). Finally, a European study [22] found a The prevalence of HCV infection was 26% (62/243) post-transplantation prevalence of 27% (35/132) but in males vs 35% (44/127) in females. For HGV infec-with a greater prevalence in the HBV infected subgroup tion, this prevalence was 40% (13 33) in males vs 52% (36%, 21/58) compared to the HCV infected subgroup (11/21) in females. These greater prevalences in females (19%, 14/74). are similar but not significant. These results may indicate a different and/or independent mode of transmission for HCV and HGV Natural history of HGV infection infections. All these recipients were deliberately transfused before renal transplantation and it is unlikely The natural history of HGV infection is still under investigation. Its role in chronic hepatitis has not been that transmission from blood was much different for HCV and HGV. There should be, however, additional established [23] , although it has clearly been associated with fulminant hepatitis [24, 25] . Conversely, HGV basic differences between these two viruses, perhaps nosocomial and horizontal for HCV vs sexual transmis-infection does not seem to carry additional risks for liver disease in either renal or liver transplantation. sion for HGV, but this is only speculation.
